Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)

Clinical trial NCT04965636 · COMPLETED

Trial details

NCT number: NCT04965636
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypereosinophilic Syndrome

Start date: 2022-07-14
Primary completion: 2025-10-28
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.